NCT07708389

Brief Summary

This prospective, randomized, single-blind, assessor-blinded, parallel-group clinical trial aims to compare the effects of 970-nm diode laser and liquid nitrogen cryotherapy in patients requiring maxillary labial frenectomy. The primary objective is to compare the change in salivary cortisol levels from baseline to postoperative day 2 between the two treatment groups. Secondary objectives include comparison of postoperative pain, edema, interincisal mouth opening, analgesic consumption, operation duration, state anxiety, clinical wound healing, and adverse events. Eligible adult patients with an indication for maxillary labial frenectomy will be randomly assigned to receive either 970-nm diode laser frenectomy or liquid nitrogen cryotherapy. Salivary cortisol samples and clinical outcomes will be assessed during the early postoperative follow-up period.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
10mo left

Started Jul 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Jul 2026May 2027

First Submitted

Initial submission to the registry

July 13, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 16, 2026

Completed
14 days until next milestone

Study Start

First participant enrolled

July 30, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 2, 2027

Expected
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 21, 2027

Last Updated

July 16, 2026

Status Verified

July 1, 2026

Enrollment Period

9 months

First QC Date

July 13, 2026

Last Update Submit

July 13, 2026

Conditions

Keywords

Maxillary labial frenectomyDiode laser970-nm diode laserLiquid nitrogen cryotherapySalivary cortisolPostoperative painWound healing

Outcome Measures

Primary Outcomes (1)

  • Change in salivary cortisol level from baseline to postoperative day 2

    Salivary cortisol will be measured in unstimulated saliva samples using an ELISA method. For each participant, the change in salivary cortisol level from the preoperative baseline measurement to postoperative day 2 will be calculated and compared between the two intervention groups. Results will be recorded in nmol/L.

    Baseline and postoperative day 2

Secondary Outcomes (9)

  • Change in salivary cortisol level from baseline to postoperative day 7

    Baseline and postoperative day 7

  • Change in postoperative edema

    Baseline, postoperative day 2, and postoperative day 7

  • Postoperative pain intensity

    Postoperative 6 hours, 12 hours, 24 hours, day 2, and day 7

  • Change in interincisal mouth opening

    Baseline, postoperative day 2, and postoperative day 7

  • Total analgesic consumption during the first postoperative week

    Postoperative days 0 to 7

  • +4 more secondary outcomes

Study Arms (2)

970-nm Diode Laser Frenectomy

EXPERIMENTAL

Participants randomized to this arm will undergo maxillary labial frenectomy using a 970-nm diode laser. The procedure will be performed with a SiroLaser Advance device at 970 nm wavelength, 2 W power, continuous wave mode, and a 320-micrometer sterile fiber tip using a contact technique. The total laser application time will be standardized as 2 minutes. The surgical area will not be sutured and will be left to heal by secondary intention.

Procedure: 970-nm Diode Laser Frenectomy

Liquid Nitrogen Cryotherapy

EXPERIMENTAL

Participants randomized to this arm will receive liquid nitrogen cryotherapy applied to the maxillary labial frenulum region using an open-spray technique. Two freeze-thaw cycles will be performed; each freezing cycle will last 15 seconds, with passive complete thawing between cycles. No mechanical excision will be performed after cryotherapy. The target tissue is expected to be eliminated through cryogenic necrosis and secondary healing. The surgical area will not be sutured.

Procedure: Liquid Nitrogen Cryotherapy

Interventions

Maxillary labial frenectomy will be performed using a 970-nm diode laser device at 2 W power in continuous wave mode with a 320-micrometer sterile fiber tip using a contact technique. The total laser application time will be standardized as 2 minutes. The surgical area will not be sutured and will be left to heal by secondary intention.

Also known as: Diode laser frenectomy
970-nm Diode Laser Frenectomy

Liquid nitrogen cryotherapy will be applied to the maxillary labial frenulum region using an open-spray technique. Two freeze-thaw cycles will be performed; each freezing cycle will last 15 seconds, with passive complete thawing between cycles. No mechanical excision will be performed after cryotherapy, and the surgical area will not be sutured.

Liquid Nitrogen Cryotherapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 65 years.
  • Systemically healthy, ASA I status.
  • Clinical indication for maxillary labial frenectomy.
  • Ability to attend postoperative follow-up visits.
  • Provision of written informed consent.

You may not qualify if:

  • Systemic or local corticosteroid use within the last 6 months.
  • Endocrine disease that may affect cortisol levels.
  • Pregnancy or lactation.
  • Active oral infection.
  • Chronic analgesic or anti-inflammatory drug use.
  • Psychiatric medication use.
  • Smoking.
  • ASA II or higher systemic status.
  • Inability to attend follow-up visits.
  • Refusal to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kutahya Health Sciences University Faculty of Dentistry

Kütahya, Kütahya, 43020, Turkey (Türkiye)

Location

Related Publications (3)

  • Opaleye T, Okoturo E, Adesina OA, Oyapero A, Salami Y, Wemambu JC. Salivary Cortisol as a Stress Monitor During Third Molar Surgery. J Maxillofac Oral Surg. 2022 Dec;21(4):1112-1118. doi: 10.1007/s12663-020-01480-2. Epub 2020 Nov 22.

    PMID: 36896050BACKGROUND
  • Georgakopoulou E, Loumou P, Sgouros D, Chaurasia A, Panagiotopoulos A. Cryosurgery in oral lesions. J Clin Exp Dent. 2025 Oct 1;17(10):e1257-e1266. doi: 10.4317/jced.63133. eCollection 2025 Oct.

    PMID: 41255399BACKGROUND
  • Sobouti F, Moallem Savasari A, Aryana M, Hakimiha N, Dadgar S. Maxillary labial frenectomy: a randomized, controlled comparative study of two blue (445 nm) and infrared (980 nm) diode lasers versus surgical scalpel. BMC Oral Health. 2024 Jul 25;24(1):843. doi: 10.1186/s12903-024-04364-w.

    PMID: 39054510BACKGROUND

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Muhammet Yasin Pektaş, Asst. Prof, DDS

    Kutahya Health Sciences University, Faculty of Dentistry, Department of Oral and Maxillofacial Surgery

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Muhammet Yasin Pektaş, Asst. Prof, DDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Postoperative clinical outcome assessments, including wound healing scoring, will be performed by an outcomes assessor who is blinded to the allocated intervention group.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized into two parallel intervention groups: 970-nm diode laser frenectomy and liquid nitrogen cryotherapy.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 13, 2026

First Posted

July 16, 2026

Study Start

July 30, 2026

Primary Completion (Estimated)

May 2, 2027

Study Completion (Estimated)

May 21, 2027

Last Updated

July 16, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations